GlassScriptPhysician profile
John R Busby
NPI 1578529970
$3,349.78
in general payments reported to CMS, 2019-2025
24 companies · $570 in 2025
The $570 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $430 · 2021: $425 · 2022: $251 · 2023: $214 · 2024: $587 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,370.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $622.08 | 2021-2025 | Corevalve Evolut R, Avalus |
| Ethicon US, LLC | $424.15 | 2019-2025 | Vistaseal, Evarrest, Prolene |
| Medtronic Vascular, INC. | $406.19 | 2019-2020 | |
| Baxter Healthcare | $384.34 | 2022-2025 | Coseal, Tisseel, Recothrom |
| Abiomed | $243.99 | 2019-2023 | Impella |
| Edwards Lifesciences Corporation | $216.05 | 2019-2022 | |
| Boston Scientific Corporation | $214.16 | 2020-2021 | |
| Atricure, INC. | $203.33 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryosphere Cryoablation System |
| Lemaitre Vascular, INC. | $142.76 | 2025 | Xenosure Biologic Patch, Artegraft Vascular Graft |
| Silk Road Medical, INC. | $81.14 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Livanova USA, INC. | $74.74 | 2019 | |
| W. L. Gore & Associates, INC. | $56.78 | 2019 | |
| Depuy Synthes Sales INC. | $44.89 | 2024 | Cranios Reinforced, Matrixrib |
| Zimmer Biomet Holdings, INC. | $42.02 | 2021-2022 | |
| Paragonix Technologies, INC. | $28.14 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.41 | 2022 | |
| Bolton Medical INC | $20.18 | 2019 | |
| Cardiovascular Systems INC. | $20.00 | 2021 | |
| Haemonetics Corporation | $19.79 | 2023 | Teg6s Hemostasis System |
| Bard Access Systems, INC. | $19.02 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.80 | 2023 | Lifevest |
| Lsi Solutions INC | $16.18 | 2024 | Cor-Knot |
| Elutia, INC. | $13.99 | 2019 | |
| Glaxosmithkline, LLC. | $13.65 | 2025 | Ojjaara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Busby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.